You don't need to rely on memory, the company just

You don't need to rely on memory, the company just stated not too long ago they were considering another reverse split. Don't worry though, no larger than 300:1. They have been trying to get decent financing for their entire existence and are basically in a constant do or die situation. To their credit, they have managed to persevere, albeit at the great expense of shareholders. Also, while brining up old memories, lets not forget how "why sell for x today when you can sell for 10x in the future" worked out last time around. Instead of 10x we got x/100. Lets just hope ESS is not the new Lympro. I know they are apples and oranges, but its not too big of a stretch to expect "unforeseen challenges" or some other excuse. This viewpoint is on the pessimistic end of the spectrum, but I'd rather set the bar low this time around.